NCT05715281 2025-11-25Testing the Combination of Anti-cancer Drugs Atezolizumab and Tiragolumab in People With Advanced Stage Rare Cancers, RARE3 TrialNational Cancer Institute (NCI)Phase 2 Active not recruiting12 enrolled